N. Smrekar

Comparison of radon doses based on different radon monitoring approaches.

Z. Žunić, J. Vaupotic, N. Smrekar, 2017, Journal of environmental radioactivity.

Dendritic Cell Profiles in the Inflamed Colonic Mucosa Predict the Responses to Tumor Necrosis Factor Alpha Inhibitors in Inflammatory Bowel Disease

A. Kopitar, A. Ihan, I. Ferkolj, 2018, Radiology and oncology.

Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label

A. Gils, M. Ferrante, G. Novak, 2020, European journal of gastroenterology & hepatology.

Optimised infliximab monotherapy is as effective as optimised combination therapy, but is associated with higher drug consumption in inflammatory bowel disease

G. Novak, J. Hanžel, Polona Švegl, 2019, Alimentary pharmacology & therapeutics.

Success and safety of high infliximab trough levels in inflammatory bowel disease

J. Osredkar, R. Orel, G. Novak, 2018, Scandinavian Journal of Gastroenterology.

IgA Nephropathy in a Patient Treated with Adalimumab

N. Kojc, J. Lindič, D. Kovač, 2021, Case Reports in Nephrology and Dialysis.

Ustekinumab concentrations shortly after escalation to monthly dosing may identify endoscopic remission in refractory Crohn’s disease

G. Novak, J. Hanžel, I. Grabnar, 2021, European journal of gastroenterology & hepatology.

Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn's Disease Likely to Achieve Endoscopic and Biochemical Remission.

Debby Thomas, G. Novak, J. Hanžel, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease

A. Gils, G. Novak, J. Hanžel, 2019, United European gastroenterology journal.

Ustekinumab Dosing Individualization in Crohn’s Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model

Debby Thomas, G. Novak, J. Hanžel, 2021, Pharmaceutics.

Biopsies from ulcer edge yield higher histological activity scores than biopsies from non-ulcerated mucosa in active ulcerative colitis

G. Novak, J. Hanžel, N. Zidar, 2023, European journal of gastroenterology & hepatology.

P603 Vedolizumab trough levels at Week 6 predict endoscopic and clinical remission in inflammatory bowel disease

A. Gils, G. Novak, J. Hanžel, 2018 .